| Cross-talk between the ErbB/HER family and the type I insulin-like growth factor receptor signaling pathway in breast cancer Q Jin, FJ Esteva Journal of mammary gland biology and neoplasia 13, 485-498, 2008 | 183 | 2008 |
| Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells Q Jin, LX Yuan, D Boulbes, JM Baek, YN Wang, D Gomez-Cabello, ... Breast Cancer Research 12, 1-15, 2010 | 166 | 2010 |
| Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin Q Jin, L Feng, C Behrens, BN Bekele, II Wistuba, WK Hong, HY Lee Cancer research 67 (24), 11630-11639, 2007 | 105 | 2007 |
| Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer development WY Kim, Q Jin, SH Oh, ES Kim, YJ Yang, DH Lee, L Feng, C Behrens, ... Cancer research 69 (18), 7439-7448, 2009 | 91 | 2009 |
| Insulin-like Growth Factor-I Receptor Signaling Pathway Induces Resistance to the Apoptotic Activities of SCH66336 (Lonafarnib) through Akt/Mammalian Target of Rapamycin … SH Oh, Q Jin, ES Kim, FR Khuri, HY Lee Clinical cancer research 14 (5), 1581-1589, 2008 | 66 | 2008 |
| CD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cells DR Boulbes, GB Chauhan, Q Jin, C Bartholomeusz, FJ Esteva Breast cancer research and treatment 151, 501-513, 2015 | 56 | 2015 |
| Survivin expression in normal human bronchial epithelial cells: an early and critical step in tumorigenesis induced by tobacco exposure Q Jin, DG Menter, LI Mao, WK Hong, HY Lee Carcinogenesis 29 (8), 1614-1622, 2008 | 56 | 2008 |
| HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancer DR Boulbes, ST Arold, GB Chauhan, KV Blachno, N Deng, WC Chang, ... Molecular oncology 9 (3), 586-600, 2015 | 43 | 2015 |
| The tobacco-specific carcinogen-operated calcium channel promotes lung tumorigenesis via IGF2 exocytosis in lung epithelial cells HJ Boo, HY Min, HJ Jang, HJ Yun, JK Smith, Q Jin, HJ Lee, D Liu, ... Nature communications 7 (1), 12961, 2016 | 37 | 2016 |
| Serum CD44 levels and overall survival in patients with HER2-positive breast cancer JM Baek, Q Jin, J Ensor, DR Boulbes, FJ Esteva Breast cancer research and treatment 130, 1029-1036, 2011 | 29 | 2011 |
| Transcriptional and posttranslational regulation of insulin-like growth factor binding protein-3 by Akt3 Q Jin, HJ Lee, HY Min, JK Smith, SJ Hwang, YM Whang, WY Kim, YH Kim, ... Carcinogenesis 35 (10), 2232-2243, 2014 | 13 | 2014 |
| S2-7: Mechanisms of Action and Biological Significance of HER2 Mutations in HER2− Overexpressing Breast Cancer. DR Boulbes, Q Jin, ST Arold, JE Ladbury, D Yu, FJ Esteva Cancer Research 71 (24_Supplement), S2-7-S2-7, 2011 | 1 | 2011 |
| Abstract# 793: Elevated epithelial i nsulin-like growth factor expression is a risk factor for lung cancer d evelopment WY Kim, Q Jin, SH Oh, E Kim, Y Yang, L Feng, C Behrens, L Prudkin, ... Cancer Research 69 (9_Supplement), 793-793, 2009 | 1 | 2009 |
| Expression of phospho (p)-AMP-activated protein kinase (AMPK) in lung cancer WN William Jr, Q Jin, ES Kim, L Feng, L Prudkin, JJ Lee, C Behrens, ... Journal of Clinical Oncology 26 (15_suppl), 11085-11085, 2008 | 1 | 2008 |
| Tobacco-specific nitrosamine, 4-(methylnitrosamino)-3-(3-pyridyl)-1-butanone, facilitates lung carcinogenesis by inducing survivin expression in normal human bronchial … Q Jin, I Wistuba, L Feng, C Behrens, B Bekele, L Mao, W Hong, HY Lee Cancer Research 67 (9_Supplement), 2428-2428, 2007 | 1 | 2007 |
| Akt regulates insulin-like growth factor binding protein-3 by modulating its expression in human non-small cell lung cancer cells. Q Jin, HY Min, YM Whang, YH Kim, HY Lee Cancer Research 73 (8_Supplement), 5265-5265, 2013 | | 2013 |
| P2-01-14: High Level of CD44 Expression and Soluble CD44 Secretion Mediate Trastuzumab Resistance in HER2 Positive Breast Cancer. Q Jin, JM Baek, DR Boulbes, FJ Esteva Cancer Research 71 (24_Supplement), P2-01-14-P2-01-14, 2011 | | 2011 |
| EGFR and K-Ras mutations and resistance of lung cancer to the IGF-1R tyrosine kinase inhibitors WY Kim, Q Jin, L Prudkin, JS Kim, F Morgillo, L Feng, ES Kim, ... Cancer Research 70 (8_Supplement), 4127-4127, 2010 | | 2010 |
| Abstract# 4292: Recombinant human insulin-like growth factor binding protein-3 induces an anti-proliferative effect that is potentiated by PI3K/Akt inhibition in NSCLC cells. J Smith, QJYMWHY Lee Cancer Research 69 (9_Supplement), 4292-4292, 2009 | | 2009 |
| Recombinant human insulin-like growth factor binding protein-3 induces an anti-proliferative effect that is potentiated by PI3K/Akt inhibitionin NSCLC cells. J Smith, Q Jin, YM Whang, HY Lee CANCER RESEARCH 69, 2009 | | 2009 |
